SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 17)*
| Meridian Bioscience, Inc.
|
| (Name of Issuer) |
| Common Stock
|
| (Title of Class of Securities) |
|
589584 10 1
|
| (CUSIP Number) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| [_] | Rule 13d-1(b) |
| [_] | Rule 13d-1(c) |
| [X] | Rule 13d-1(d) |
|
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (Continued on following page(s)) |
|
|
||
| CUSIP No. 589584 10 1 | 13D | Page 2 of 4 Pages |
|
|
||
| 1. | Name of Reporting Person I.R.S. Identification No. of Above Person (Entities Only). William J. Motto |
||
| 2. | Check the Appropriate Box If a Member of Group (See Instructions) | (a) [_] (b) [X] |
|
| 3. | SEC Use Only | |
| 4. | Citizenship or
Place of Organization United States of America |
|
Number Of Shares Beneficially Owned By Each Reporting Person With |
5. | Sole Voting
Power 3,538,062 |
|
| 6. | Shared Voting
Power 462,532 |
||
| 7. | Sole Dispositive
Power 3,538,062 |
||
| 8. | Shared Dispositive
Power 462,532 |
||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person 4,000,599 |
|
| 10. | Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) |
|_| | |
| 11. | Percent of Class Represented by Amount in Row (11) 27.2% |
|
| 12. | Type of Reporting Person (See Instructions) IN |
|
| Page 3 of 4 pages |
Item 1(a) Name of Issuer: Meridian Bioscience, Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
3471 River Hills Drive
Cincinnati, Ohio 45244
Item 2(a) Name of Person Filing: William J. Motto
Item 2(b) Address of Principal Business Office:
3471 River Hills Drive
Cincinnati, Ohio 45244
Item 2(c) Citizenship: U.S.A.
Item 2(d) Title of Class of Securities: Common Stock
Item 2(e) CUSIP Number: 589584 10 1
Item 3
If this
Statement is Filed Pursuant to Rule 13d-1(b), or
13d-2(b), check
whether the Person Filing is a: N/A
Item 4 Ownership:
| (a) (b) (c) |
See Item 9 of cover page. See Item 11 of cover page. See Items 5-8 of cover page. |
| The shares in Items 5, 7 and 9 include options for 60,000 shares and 5% Convertible Subordinated Debentures convertible into 3,448 shares. The number of shares shown in Items 6, 8 and 9 for Mr. Motto includes 462,532 shares held by a limited partnership and affiliated entities of which Mr. Motto is a limited partner. Mr. Motto is also a co-Trustee of the William J. Motto Revocable Trust which is the sole owner of the general partner of the limited partnership. |
Item 5 Ownership of 5% or Less of Class: N/A
Item 6 Ownership of More Than 5% on Behalf of Another Person: N/A
Item 7
Identification
and Classification of the Subsidiary which Acquired the Security being
Reported
on by the Parent Holding Company: N/A
| Page 4 of 4 pages |
Item 8 Identification and Classification of Members of the Group: N/A
Item 9 Notice of Dissolution of Group: N/A
Item 10 Certification: N/A
| After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. |
|
February 11, 2004
|